News from 3sbio inc

Jun 18, 2014, 02:22 ET

3SBio Inc. Exclusively Licenses Pegsiticase (Uricase PEG-20) to Selecta Biosciences to Develop Drug Candidate to Treat Gout

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing...

Oct 29, 2013, 06:09 ET

3SBio to Develop DJ5 for Progressive Renal Failure in ADPKD Patients

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical...

May 30, 2013, 08:50 ET

3SBio Inc. Announces Completion of Merger

 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing,...

May 24, 2013, 01:51 ET

3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement

3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing...

May 02, 2013, 01:24 ET

3SBio Inc. Announces Extraordinary General Meeting of Shareholders

3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing,...

May 01, 2013, 08:32 ET

3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2012

 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing,...

Apr 25, 2013, 04:30 ET

3SBio Inc. Adjourns Extraordinary General Meeting of Shareholders

3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing,...

Apr 24, 2013, 11:53 ET

3SBio Inc. Enters Into Amendment to Merger Agreement For "Going Private" Transaction

3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing...

Apr 22, 2013, 14:13 ET

3SBio Inc. Announces Receipt of Amended "Going Private" Proposal at $16.70 Per ADS and Intent to Adjourn Extraordinary General Meeting of Shareholders

 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing,...

Mar 24, 2013, 10:11 ET

3SBio Inc. Announces Extraordinary General Meeting of Shareholders

3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing...

Mar 18, 2013, 20:00 ET

3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2012 Results

3SBio Inc. (NASDAQ: SSRX) ("3SBio" or  "the Company"), a leading China-based biotechnology company focused on researching, developing,...

Mar 03, 2013, 08:53 ET

3SBio Inc. Schedules Unaudited Fourth Quarter and Full Year 2012 Results

 3SBio Inc. (NASDAQ: SSRX) ("3SBio"), a leading China-based biotechnology company focused on researching, developing, manufacturing and...

Feb 08, 2013, 05:29 ET

3SBio Inc. Enters Into Merger Agreement For "Going Private" Transaction

3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing...

Nov 11, 2012, 19:20 ET

3SBio Inc. Announces Unaudited Third Quarter 2012 Results

 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching,...

Oct 13, 2012, 00:15 ET

3SBio Inc. Announces Results Of 2012 Annual General Meeting

 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing,...

Oct 08, 2012, 23:35 ET

3SBio Inc. Schedules Unaudited Third Quarter 2012 Results

3SBio Inc. (NASDAQ: SSRX) ("3SBio"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing...

Sep 28, 2012, 09:38 ET

3SBio Independent Committee Selects Financial Advisor in Connection with Going Private Proposal

3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and...

Sep 16, 2012, 20:57 ET

3SBio Independent Committee Selects Legal Counsel in connection with Going Private Proposal

  3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing,...

Sep 12, 2012, 08:00 ET

3SBio Inc. Announces Receipt of "Going Private" Proposal at $15 Per ADS

3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing,...

Sep 10, 2012, 19:00 ET

3SBio Inc. to Hold 2012 Annual General Meeting on October 10, 2012

3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Analysts Review